首页>
外国专利>
Biomarker for predicting therapeutic response or prognosis of triple negative breast cancer to chemotherapeutic agents
Biomarker for predicting therapeutic response or prognosis of triple negative breast cancer to chemotherapeutic agents
展开▼
机译：预测三阴性乳腺癌对化疗药物的治疗反应或预后的生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present application discloses biomarkers capable of predicting therapeutic responsiveness and prognosis for anti-cancer agents of triple negative breast cancer and uses thereof. The marker according to the present invention may contribute to the quality of life and life extension of the patient by providing an individual optimized treatment method through accurate personalized treatment.
展开▼
